Developer of stabilized non-immunogenic mRNA platform designed to develop innovative therapies and vaccines. The company's platform uses a proprietary mRNA-modification technology and lipid nanopartic...

Healthcare
Planegg, Germany
51 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$50.5M
Last Round
N/A

Get the full picture

Create a free account to unlock Ethris's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required